Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Catch Your Breath: Understanding Interstitial Lung Disease in Rheumatoid Arthritis

Jason Liebowitz, MD, FACR  |  Issue: December 2024  |  November 19, 2024

Nailfold Capillaroscopy

The final speaker was Vanessa Smith, MD, PhD, associate professor of rheumatology and head of clinics, Ghent University Hospital, Belgium, who focused on the topic of nailfold capillaroscopy. At first glance, nailfold capillaroscopy and RA-ILD may not seem to fit together. However, the purpose of Dr. Smith’s talk was to remind the audience of how important the nailfold exam is in all patients with concern for ILD to identify scleroderma-spectrum diseases. In 1973, Maricq and LeRoy published a landmark study on the use of wide field microscopy to identify patterns of abnormal nailfold capillaries in patients with connective tissue diseases.8 Cutolo further expanded on this work in later years by employing 200x magnification techniques to look at nailfold capillaries in even greater detail. In 2020, Dr. Smith joined Dr. Cutolo and others in writing a consensus paper on nailfold capillaroscopy in patients with Raynaud’s and systemic sclerosis. In this paper, the authors were able to describe nailfold density, dimension, morphology and hemorrhage to create two categories: scleroderma pattern and non-scleroderma pattern.9

The fact that only patients with scleroderma-spectrum diseases should have a scleroderma pattern on nailfold capillaroscopy is helpful when evaluating for the underlying cause of a patient’s ILD. Dr. Smith provided a clinical example in which a patient presented with ILD in a nonspecific interstitial pneumonia (NSIP) pattern with concomitant inflammatory arthritis. The initial impulse of the treating provider was to label the patient as possibly having RA-ILD, but the nailfold capillaroscopy demonstrated a scleroderma pattern. Upon further evaluation, this patient was found to have antisynthetase syndrome as the cause of his disease. In a different case, a young woman was identified as having ILD in a UIP pattern and her lab studies showed a range of low titer antibodies in a confusing pattern. Her nailfold capillaroscopy was normal, and ultimately she was diagnosed as having a genetic cause for her ILD. The main message conveyed in these cases is that the absence or presence of scleroderma pattern nailfold capillaroscopy results can aid a great deal in finding the true etiology of ILD in each patient.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In Sum

The talk  highlighted an unmet need: correctly identifying and treating patients with RA-ILD early in their disease course. Achieving success in this area is challenging, and a collaboration between rheumatologists and pulmonologists is important to improve the status quo and better patient care.


Jason Liebowitz, MDJason Liebowitz, MD, is an assistant professor of medicine in the Division of Rheumatology at Columbia University Vagelos College of Physicians and Surgeons, New York.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2024ACR Convergence 2024 RAILDInterstitial Lung Disease

Related Articles

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

    Rheumatologists Find Nailfold Capillaroscopy an Increasingly Useful Diagnostic Tool

    October 18, 2017

    Interest in viewing the nail capillaries dates to the late 17th century. Later research by Maurice Raynaud and others in the late 19th and early 20th century first established a direct link between the nailfold capillaries and certain medical conditions. Although underutilized in the past, with the advent of modern digital equipment and the validation…

    Capillaroscopy a Safe and Direct Method for SSc Diagnosis

    June 13, 2011

    Seeing vessels clearly can help with discovery and timely treatment

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences